anti pdia1 (Cell Signaling Technology Inc)
Cell Signaling Technology Inc is a verified supplier 
Cell Signaling Technology Inc manufactures this product 
96
Structured Review
Cell Signaling Technology Inc
anti pdia1
Anti Pdia1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 395 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pdia1/PDI+Rabbit+mAb/pmc12183083-222-28-29
Average 96 stars, based on 395 article reviews
Anti Pdia1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 395 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pdia1/PDI+Rabbit+mAb/pmc12183083-222-28-29
Average 96 stars, based on 395 article reviews
anti pdia1 - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
shRNA:Article Title: Fabrication and characterization of soy protein isolation-ferulic acid antioxidant hydrogels. Article Snippet: The NLRP3 inflammasome is a cytosolic protein complex that regulates innate immune signaling in response to diverse pathogenic insults through the proteolytic processing and secretion of pro-inflammatory cytokines such as IL1β.. Hyperactivation of NLRP3 inflammasome signaling is implicated in the onset and pathogenesis of numerous diseases, motivating the discovery of new strategies to suppress NLRP3 inflammasome activity.. We sought to define the potential for the proteostasis regulator AA147 to inhibit the assembly and activation of the NLRP3 inflammasome. Article Title: Pharmacologic Targeting of PDIA1 Inhibits NLRP3 Inflammasome Assembly and Activation Article Snippet: G; Addgene cat. 12259). .. Mission shRNA plasmids in pLKO.1 vectors were obtained from La Jolla Institute for Allergy and Immunology (LJI) and were previously used in Paxman et al.38 The specific target sequences for viral plasmid of these shRNAs are below: The following primary antibodies were diluted as noted in 5 % bovine serum albumin (BSA) in TBS and incubated overnight: KDEL (1 : 1000; Enzo cat. ADI-SPA-827-F), NLRP3 (1 : 1000; Cell Signaling cat. 15101), CASP1 (1 : 1000; Cell Signaling cat. 3866), ASC (1 : 1000, Cell Signaling cat. 13833), IL-1β (1 : 1000, GeneTex cat. GTX74034), Article Title: Pharmacologic Targeting of PDIA1 Inhibits NLRP3 Inflammasome Assembly and Activation Article Snippet: G; Addgene cat. 12259). .. Mission shRNA plasmids in pLKO.1 vectors were obtained from La Jolla Institute for Allergy and Immunology (LJI) and were previously used in Paxman et al.38 The specific target sequences for viral plasmid of these shRNAs are below: Target (Designation) shRNA sequence The following primary antibodies were diluted as noted in 5% bovine serum albumin (BSA) in TBS and incubated overnight: KDEL (1:1000; Enzo cat. ADI-SPA-827-F), NLRP3 (1:1000; Cell Signaling cat. 15101), CASP1 (1:1000; Cell Signaling cat. 3866), ASC (1:1000, Cell Signaling cat. 13833), IL-1β (1:1000, GeneTex cat. GTX74034), Plasmid Preparation:Article Title: Fabrication and characterization of soy protein isolation-ferulic acid antioxidant hydrogels. Article Snippet: The NLRP3 inflammasome is a cytosolic protein complex that regulates innate immune signaling in response to diverse pathogenic insults through the proteolytic processing and secretion of pro-inflammatory cytokines such as IL1β.. Hyperactivation of NLRP3 inflammasome signaling is implicated in the onset and pathogenesis of numerous diseases, motivating the discovery of new strategies to suppress NLRP3 inflammasome activity.. We sought to define the potential for the proteostasis regulator AA147 to inhibit the assembly and activation of the NLRP3 inflammasome. Article Title: Pharmacologic Targeting of PDIA1 Inhibits NLRP3 Inflammasome Assembly and Activation Article Snippet: G; Addgene cat. 12259). .. Mission shRNA plasmids in pLKO.1 vectors were obtained from La Jolla Institute for Allergy and Immunology (LJI) and were previously used in Paxman et al.38 The specific target sequences for viral plasmid of these shRNAs are below: The following primary antibodies were diluted as noted in 5 % bovine serum albumin (BSA) in TBS and incubated overnight: KDEL (1 : 1000; Enzo cat. ADI-SPA-827-F), NLRP3 (1 : 1000; Cell Signaling cat. 15101), CASP1 (1 : 1000; Cell Signaling cat. 3866), ASC (1 : 1000, Cell Signaling cat. 13833), IL-1β (1 : 1000, GeneTex cat. GTX74034), Article Title: Pharmacologic Targeting of PDIA1 Inhibits NLRP3 Inflammasome Assembly and Activation Article Snippet: G; Addgene cat. 12259). .. Mission shRNA plasmids in pLKO.1 vectors were obtained from La Jolla Institute for Allergy and Immunology (LJI) and were previously used in Paxman et al.38 The specific target sequences for viral plasmid of these shRNAs are below: Target (Designation) shRNA sequence The following primary antibodies were diluted as noted in 5% bovine serum albumin (BSA) in TBS and incubated overnight: KDEL (1:1000; Enzo cat. ADI-SPA-827-F), NLRP3 (1:1000; Cell Signaling cat. 15101), CASP1 (1:1000; Cell Signaling cat. 3866), ASC (1:1000, Cell Signaling cat. 13833), IL-1β (1:1000, GeneTex cat. GTX74034), Incubation:Article Title: Fabrication and characterization of soy protein isolation-ferulic acid antioxidant hydrogels. Article Snippet: The NLRP3 inflammasome is a cytosolic protein complex that regulates innate immune signaling in response to diverse pathogenic insults through the proteolytic processing and secretion of pro-inflammatory cytokines such as IL1β.. Hyperactivation of NLRP3 inflammasome signaling is implicated in the onset and pathogenesis of numerous diseases, motivating the discovery of new strategies to suppress NLRP3 inflammasome activity.. We sought to define the potential for the proteostasis regulator AA147 to inhibit the assembly and activation of the NLRP3 inflammasome. Article Title: Pharmacologic Targeting of PDIA1 Inhibits NLRP3 Inflammasome Assembly and Activation Article Snippet: G; Addgene cat. 12259). .. Mission shRNA plasmids in pLKO.1 vectors were obtained from La Jolla Institute for Allergy and Immunology (LJI) and were previously used in Paxman et al.38 The specific target sequences for viral plasmid of these shRNAs are below: The following primary antibodies were diluted as noted in 5 % bovine serum albumin (BSA) in TBS and incubated overnight: KDEL (1 : 1000; Enzo cat. ADI-SPA-827-F), NLRP3 (1 : 1000; Cell Signaling cat. 15101), CASP1 (1 : 1000; Cell Signaling cat. 3866), ASC (1 : 1000, Cell Signaling cat. 13833), IL-1β (1 : 1000, GeneTex cat. GTX74034), Article Title: Pharmacologic Targeting of PDIA1 Inhibits NLRP3 Inflammasome Assembly and Activation Article Snippet: G; Addgene cat. 12259). .. Mission shRNA plasmids in pLKO.1 vectors were obtained from La Jolla Institute for Allergy and Immunology (LJI) and were previously used in Paxman et al.38 The specific target sequences for viral plasmid of these shRNAs are below: Target (Designation) shRNA sequence The following primary antibodies were diluted as noted in 5% bovine serum albumin (BSA) in TBS and incubated overnight: KDEL (1:1000; Enzo cat. ADI-SPA-827-F), NLRP3 (1:1000; Cell Signaling cat. 15101), CASP1 (1:1000; Cell Signaling cat. 3866), ASC (1:1000, Cell Signaling cat. 13833), IL-1β (1:1000, GeneTex cat. GTX74034), Sequencing:Article Title: Pharmacologic Targeting of PDIA1 Inhibits NLRP3 Inflammasome Assembly and Activation Article Snippet: G; Addgene cat. 12259). .. Mission shRNA plasmids in pLKO.1 vectors were obtained from La Jolla Institute for Allergy and Immunology (LJI) and were previously used in Paxman et al.38 The specific target sequences for viral plasmid of these shRNAs are below: Target (Designation) shRNA sequence The following primary antibodies were diluted as noted in 5% bovine serum albumin (BSA) in TBS and incubated overnight: KDEL (1:1000; Enzo cat. ADI-SPA-827-F), NLRP3 (1:1000; Cell Signaling cat. 15101), CASP1 (1:1000; Cell Signaling cat. 3866), ASC (1:1000, Cell Signaling cat. 13833), IL-1β (1:1000, GeneTex cat. GTX74034), |
